Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | THRB | P10828 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 7/20 | 0.47 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.47 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.47 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.47 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.41 |
| ▸ | BLM | P54132 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.41 |
| ▸ | GABRP | O00591 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28384994 | 0.97 | KMT2A (0.50) | KMT2ATHRBCYP1A2MEN1ALDH1A1 | |
| SCHEMBL10629764 | 0.87 | LMNA (0.56) | KMT2ATHRBCYP1A2MEN1ALDH1A1 | |
| SCHEMBL21983371 | 0.87 | LMNA (0.52) | KMT2ATHRBCYP1A2MEN1ALDH1A1 | |
| SCHEMBL3838466 | 0.86 | THRB (0.46) | KMT2ATHRBCYP1A2MEN1ALDH1A1 | |
| SCHEMBL10338097 | 0.84 | ALDH1A1 (0.45) | KMT2ATHRBCYP1A2MEN1ALDH1A1 | |
| SCHEMBL28164678 | 0.84 | ALDH1A1 (0.61) | KMT2ATHRBCYP1A2MEN1ALDH1A1 | |
| SCHEMBL21118980 | 0.83 | CYP1A2 (0.41) | KMT2ATHRBCYP1A2MEN1ALDH1A1 | |
| SCHEMBL22422223 | 0.83 | CYP1A2 (0.41) | KMT2ATHRBCYP1A2MEN1ALDH1A1 | |
| SCHEMBL2029796 | 0.81 | — | — | |
| SCHEMBL123829 | 0.81 | KMT2A (0.52) | KMT2ATHRBCYP1A2MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661892-A1 | TNF-ALPHA BINDING AGENTS AND METHODS OF USING THE SAME | Navigen, Inc. (US) | 2025-12-17 | — | — | EP | claimed |
| CN-119909235-A | Medical lubricant and preparation method thereof | 河北医科大学第一医院 | 2025-05-02 | — | — | CN | claimed |
| WO-2024168055-A1 | TNF-ALPHA BINDING AGENTS AND METHODS OF USING THE SAME | NAVIGEN, INC. (US) | 2024-08-15 | — | — | WO | claimed |
| US-20230127824-A1 | IODINE LABELED HYDROGELS AND PRECURSORS THEREOF WITH IMPROVED RADIOPACITY | BOSTON SCIENTIFIC SCIMED INC. (US) | 2023-04-27 | — | — | US | claimed |
| CN-109069577-B | D-peptide inhibitors of HIV entry and methods of use | 纳维根公司 | 2022-08-19 | — | — | CN | claimed |
| EP-3399994-B1 | D-PEPTIDE INHIBITORS OF HIV ENTRY AND METHODS OF USE | NAVIGEN INC (US) | 2020-09-16 | — | — | EP | claimed |
| US-20190023748-A1 | D-PEPTIDE INHIBITORS OF HIV ENTRY AND METHODS OF USE | THE UNIVERSITY OF UTAH | 2019-01-24 | — | — | US | claimed |
| EP-3399994-A1 | D-PEPTIDE INHIBITORS OF HIV ENTRY AND METHODS OF USE | Navigen, Inc. (US) | 2018-11-14 | — | — | EP | claimed |
| WO-2017120549-A1 | D-PEPTIDE INHIBITORS OF HIV ENTRY AND METHODS OF USE | NAVIGEN, INC. (US) | 2017-07-13 | — | — | WO | claimed |
| EP-4737504-A2 | CATIONIC LIPID, LIPOSOME CONTAINING CATIONIC LIPID, AND NUCLEIC-ACID PHARMACEUTICAL COMPOSITION CONTAINING LIPOSOME AND FORMULATION AND APPLICATION THEREOF | Xiamen Sinopeg Biotech Co., Ltd. (CN) | 2026-05-06 | — | — | EP | disclosed |
| EP-4276090-B1 | CATIONIC LIPID, LIPOSOME CONTAINING CATIONIC LIPID, AND NUCLEIC-ACID PHARMACEUTICAL COMPOSITION CONTAINING LIPOSOME AND PREPARATION AND APPLICATION THEREOF | XIAMEN SINOPEG BIOTECH CO LTD (CN) | 2026-04-29 | — | — | EP | disclosed |
| EP-4661892-A1 | TNF-ALPHA BINDING AGENTS AND METHODS OF USING THE SAME | Navigen, Inc. (US) | 2025-12-17 | — | — | EP | disclosed |
| CN-119909235-A | Medical lubricant and preparation method thereof | 河北医科大学第一医院 | 2025-05-02 | — | — | CN | disclosed |
| WO-2025038709-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-02-20 | — | — | WO | disclosed |
| US-7888536-B2 | Selective and specific preparation of discrete PEG compounds | QUANTA BIODESIGN, LTD. (US) | 2011-02-15 | — | — | US | disclosed |
| US-20080317668-A1 | Integrin Targeted Synthetic Ligands for Diagnostic and Therapeutic Applications | BRACCO IMAGING S.P.A. (IT) | 2008-12-25 | — | — | US | disclosed |
| US-20070053840-A1 | Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents | HEALTH RESEARCH, INC. (US) | 2007-03-08 | — | — | US | disclosed |
| EP-0714903-B1 | Carbohydrate conjugates as cell adhesion inhibitors | GLYCOREX AB (SE) | 2002-05-15 | — | — | EP | disclosed |
| US-5858994-A | BIND TO SELECTIN RECEPTORS | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-01-12 | — | — | US | disclosed |
| EP-0714903-A1 | New carbohydrate conjugates as cell adhesion inhibitors | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-06-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190023748-A1 | D-PEPTIDE INHIBITORS OF HIV ENTRY AND METHODS OF USE | DNPEP, ANPEP, CD4 | KMT2A 4842/4885THRB 3010/4885CYP1A2 4883/4885 |
| US-20070053840-A1 | Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents | VHL, HMBS, PPOX | KMT2A 4466/4885THRB 1139/4885CYP1A2 4839/4885 |
| US-20080317668-A1 | Integrin Targeted Synthetic Ligands for Diagnostic and Therapeutic Applications | ITGA2B, ITGB2, ITGB1 | KMT2A 3272/4885THRB 208/4885CYP1A2 4845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.